Yarrow Bioscience Inc. – Filings and Transcripts

NASDAQ: YARW
Share price (11/6/26): $15.60
Market cap (11/6/26): $145 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Updated info for already-effective prospectus

Business combination disclosure

Business combination disclosure

Ownership Filter

News Filter

Material Definitive Agreement, Financial Statements or Exhibits

Part I, Item 1. Business

Index to Financial Statements

Announces Closing of Merger With VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-In-Class Treatment for Graves’ Disease and Thyroid Eye Disease

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission